Related Experiment Video
Updated: Aug 4, 2026

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice
Published on: January 31, 2020
Rheumatoid arthritis in a patient with primary hypogammaglobulinaemia
R Hermaszewski1, R Ratnavel, A D Webster
1Northwick Park Hospital, Harrow, Middlesex.
This study presents a rare case of rheumatoid disease developing without antibodies in a patient with primary hypogammaglobulinaemia. It highlights novel insights into the complex pathophysiology of rheumatoid arthritis and inflammatory bowel disease.
Area of Science:
- Immunology
- Rheumatology
- Gastroenterology
Background:
- Primary hypogammaglobulinaemia is a rare immune disorder characterized by low levels of immunoglobulins.
- Rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) are chronic inflammatory conditions often associated with immune dysregulation.
Observation:
- A 44-year-old woman with primary hypogammaglobulinaemia was diagnosed with both classical RA and IBD.
- This patient presented with autoimmune conditions despite a lack of endogenous antibody production.
Findings:
- The development of rheumatoid disease in the absence of endogenous antibodies challenges current understandings of RA pathophysiology.
- This case suggests potential alternative pathways in the development of autoimmune diseases.
Implications:
- Further research into antibody-independent mechanisms is crucial for understanding RA and IBD.
- This case may inform diagnostic and therapeutic strategies for patients with hypogammaglobulinaemia and autoimmune conditions.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management

